EUVIMEDEUVIMED entdecken
Open Access

Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction

Duaa Abdallah, Jake Johnson, Fang Qiu, Whitney Goldner, Apar Kishor Ganti, Anupam Kotwal iD

Thyroid® · 01.07.2025 · 35 (7) · 730-737

DOI: 10.1089/thy.2025.0076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, erschienen am 01.07.2025. Verfasst von Duaa Abdallah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Thyrotropin, Hormone Replacement Therapy, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsThyrotropinHormone Replacement TherapyNeoplasmsThyroid DiseasesHypothyroidismHumansFemaleMiddle AgedMaleRetrospective StudiesAgedAdultThyroxine

Stichwörter der Autor:innen

hypothyroidismimmune-related adverse eventsimmunotherapythyroiditisthyrotoxicosis

Substanzen

Immune Checkpoint InhibitorsThyrotropinThyroxine

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Sanford Diabetes & Thyroid Clinic, Sanford Health, Sioux Falls, South Dakota, USA.
  • Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Anupam Kotwal

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Abdallah, D., Johnson, J., Qiu, F., Goldner, W., Ganti, A. K., & Kotwal, A. (2025). Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction. Thyroid®, 35(7), 730-737. https://doi.org/10.1089/thy.2025.0076

Vancouver

Abdallah D, Johnson J, Qiu F, Goldner W, Ganti AK, Kotwal A. Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction. Thyroid®. 2025;35(7):730-737. doi:10.1089/thy.2025.0076

BibTeX
@article{Abdallah2025,
  author = {Abdallah, Duaa and Johnson, Jake and Qiu, Fang and Goldner, Whitney and Ganti, Apar Kishor and Kotwal, Anupam},
  title = {Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction},
  journal = {Thyroid®},
  year = {2025},
  volume = {35},
  number = {7},
  pages = {730--737},
  doi = {10.1089/thy.2025.0076}
}
Kostenlos starten →